NO20043860L - Custodian, carrier materials for Custodian and method of manufacture thereof - Google Patents

Custodian, carrier materials for Custodian and method of manufacture thereof

Info

Publication number
NO20043860L
NO20043860L NO20043860A NO20043860A NO20043860L NO 20043860 L NO20043860 L NO 20043860L NO 20043860 A NO20043860 A NO 20043860A NO 20043860 A NO20043860 A NO 20043860A NO 20043860 L NO20043860 L NO 20043860L
Authority
NO
Norway
Prior art keywords
carrier
custodian
carrier materials
agent
manufacture
Prior art date
Application number
NO20043860A
Other languages
Norwegian (no)
Inventor
Gabriele Reich
Berthold Kohler
Original Assignee
Stoess & Co Gelatine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine
Publication of NO20043860L publication Critical patent/NO20043860L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed are a depot medicament containing a pharmacological agent and a carrier, particularly a depot medicament to be administered parenterally, carrier materials for depot medicaments, and a method for producing said carrier materials. A set amount of an agent is released over time while the agent is preserved in its pharmacologically effective form. The carrier is produced by using a carrier material comprising a carrier polymer formed by a polypeptide and a biodegradable polyester which is covalently linked thereto.
NO20043860A 2002-02-16 2004-09-15 Custodian, carrier materials for Custodian and method of manufacture thereof NO20043860L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (en) 2002-02-16 2002-02-16 Depot medicinal products, carrier materials for depot medicinal products and processes for their production
PCT/EP2003/000725 WO2003068192A1 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Publications (1)

Publication Number Publication Date
NO20043860L true NO20043860L (en) 2004-09-15

Family

ID=27674694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043860A NO20043860L (en) 2002-02-16 2004-09-15 Custodian, carrier materials for Custodian and method of manufacture thereof

Country Status (17)

Country Link
EP (1) EP1474110B1 (en)
AT (1) ATE369123T1 (en)
AU (1) AU2003210181A1 (en)
BR (1) BR0307675A (en)
DE (2) DE10206517A1 (en)
DK (1) DK1474110T3 (en)
EA (1) EA006988B1 (en)
ES (1) ES2289304T3 (en)
HU (1) HUP0500119A3 (en)
IL (2) IL162868A0 (en)
MX (1) MXPA04006982A (en)
NO (1) NO20043860L (en)
NZ (1) NZ533103A (en)
PL (1) PL371785A1 (en)
PT (1) PT1474110E (en)
WO (1) WO2003068192A1 (en)
ZA (1) ZA200403979B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
DE102007011606A1 (en) 2007-03-02 2008-09-04 Carl Freudenberg Kg Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material
US12520859B2 (en) 2020-01-13 2026-01-13 Cargill, Incorporated Turkey collagen hydrolysates and methods of making

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
CA2214889C (en) * 1995-03-10 2005-05-24 Hans Koll Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof
DE19813174A1 (en) * 1998-03-25 1999-05-27 Schering Ag Gas-filled microparticles, used for administering biologically active substances
US6384105B1 (en) * 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)

Also Published As

Publication number Publication date
IL162868A (en) 2008-03-20
EP1474110A1 (en) 2004-11-10
EA006988B1 (en) 2006-06-30
MXPA04006982A (en) 2004-11-10
HUP0500119A2 (en) 2005-07-28
ATE369123T1 (en) 2007-08-15
PT1474110E (en) 2007-10-01
WO2003068192A1 (en) 2003-08-21
DE10206517A1 (en) 2003-09-04
IL162868A0 (en) 2005-11-20
BR0307675A (en) 2005-01-11
EP1474110B1 (en) 2007-08-08
NZ533103A (en) 2007-04-27
ZA200403979B (en) 2004-11-29
PL371785A1 (en) 2005-06-27
HUP0500119A3 (en) 2008-04-28
ES2289304T3 (en) 2008-02-01
DK1474110T3 (en) 2007-12-10
AU2003210181A1 (en) 2003-09-04
EA200401012A1 (en) 2005-04-28
DE50307874D1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
Buffat Synthesis of piperidines
DE60018600D1 (en) BIOACTIVE COMPOUND COMPOSITE FOR "TISSUE ENGINEERING"
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
DE602006014692D1 (en) FILM WITH CLEANER
ATE368054T1 (en) COMPOUNDS AND METHODS FOR MODULATING OCCLUDIN-DEPENDENT TISSUE PERMEABILITY
DE60034819D1 (en) HYDROXY-PHENOXYETHERPOLYMERS IN PAPER MANUFACTURE
MXPA03003473A (en) Methods of producing oxazolidinone compounds.
NZ591802A (en) Oral and personal care compositions and methods
CA2476622A1 (en) A transdermal patch
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
MY134275A (en) Multi-layer film and medicine container using the same
ATE330943T1 (en) PRODUCTION PROCESS OF HUPERZINE A AND THEIR ANALOGUES AND COMPOUNDS USEFUL THEREOF
ATE378042T1 (en) DRUGS WITH DISCOVERED TASTE IN BRUSHING MULTIPARTICLES
DE60305438D1 (en) LYOPHILIZED PHARMACEUTICAL COMPOSITION OF PROPOFOL
DE50206912D1 (en) METHOD FOR CONTINUOUS PRODUCTION AND COATING OF SBC-BASED SELF-CONTAINING MATERIALS WITH AT LEAST ONE PHARMACEUTICAL AGENT
ATE441359T1 (en) STETHOSCOPE
NO20043860L (en) Custodian, carrier materials for Custodian and method of manufacture thereof
ATE332799T1 (en) METHOD AND DEVICES FOR PRODUCING FIBER-REINFORCED COMPONENTS
AU2067802A (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
ES2065688T3 (en) CONTAINER AND PROCEDURE FOR ITS MANUFACTURE.
AU6308700A (en) Method and apparatus for producing improvised music
ATE411051T1 (en) POLYPEPTIDE WHICH CONJUGATE CONTAINS DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED THEREOF
DE602005009734D1 (en) IAL AND THERMOPLASTIC OR ELASTOMER MATERIAL AND METHOD FOR PRODUCING THE ARTICLE
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
GB2409661A (en) Composite materials

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application